Kodiak Sciences Inc.KOD

Healthcare
Neutral

ASignal's systematic analysis rates KOD as Neutral. Kodiak Sciences Inc. has a market cap of $1.94B, and a 0.0% net margin.

Reflects the latest available analysis · analyzed Jun 7, 2026

The case on KOD

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Strong financial health score (0.8)
  • Low debt-to-equity ratio (0.50x)
  • High cash position ($169.53M)
  • Current ratio of 3.54x indicates solid liquidity
  • RSI near oversold level (32.91) suggests potential reversal
VS
Bear case
  • Negative MACD histogram (-0.489)
  • Price below both SMA20 and SMA50
  • Negative price momentum (-0.143)
  • Negative return on equity (-208.80%)
  • Negative operating and net margins
  • Negative free cash flow (-$52.15M)

Key facts

Sector
Healthcare
Market cap
$1.94B
Gross margin
0.0%
Net margin
0.0%
Price (Jun 7, 2026)
$31.05
Subscriber-only

See the full verdict on KOD

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes KOD

Most investors never get a second opinion, let alone several. ASignal runs KOD past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

Kodiak Sciences Inc. (KOD) Stock Analysis - ASignal rates it Neutral